COVID-19 Can Remain Undetected In Lungs For 18 Months: Study

DEC 14, 2023 – Authored by Amie Dahnke via The Epoch Times  The COVID-19 virus can remain in the lungs for months after an individual has been infected—even though it may be undetected by over-the-counter (OTC) tests, a new study finds. The findings, established by a research team from the Institut Pasteur in France and […]

Runaway immune reactions cause long COVID breathing problems

Author: Christopher Vaughan, Stanford Medicine 2023 Stanford Medicine researchers have found a mechanism behind one of the most common symptoms of long COVID — shortness of breath. Post COVID-19 breathing problems are caused by a condition known as lung fibrosis, when damaged lungs form scar tissue, which makes it difficult for lungs to expand and […]

Beyond epithelial damage: vascular and endothelial contributions to idiopathic pulmonary fibrosis

James May, Jane A. Mitchell, and R. Gisli Jenkins, Published September 15, 2023 – 10.1172/JCI172058 Idiopathic pulmonary fibrosis (IPF) is a progressive scarring disease of the lung with poor survival. The incidence and mortality of IPF are rising, but treatment remains limited. Currently, two drugs can slow the scarring process but often at the expense of intolerable side […]

Molecular mechanisms of COVID-19-induced pulmonary fibrosis and epithelial-mesenchymal transition

Authors: Peng Pi1† Zhipeng Zeng1† Liqing Zeng1 Bing Han1 Xizhe Bai2 Shousheng Xu3*Front. Pharmacol., 03 August 2023, Sec. Respiratory Pharmacology, Volume 14 – 2023 | As the outbreak of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first broke out in Hubei Province, China, at the end of 2019. It has brought great challenges and harms to global […]

Spectrum of Fibrotic Lung Diseases

Marlies Wijsenbeek, M.D., and Vincent Cottin, M.D.  New England Journal of Medicine 2023 Diffuse parenchymal lung diseases encompass a large number of conditions, with a wide range of causes, clinical manifestations, and imaging and pathological features, as well as variable outcomes. Despite the intrinsic heterogeneity of this group of diseases, in most of them, the […]

Post-COVID Interstitial Lung Disease and Other Lung Sequelae

Mark Barash, DOa,∗ and Vijaya Ramalingam, MD, FCCPa,b Clin Chest Med. 2023 Jun; 44(2): 263–277. Published online 2023 Mar 3. doi: 10.1016/j.ccm.2022.11.019 PMCID: PMC9983785 PMID: 37085219 Author information Copyright and License information PMC Disclaimer As the world emerges from the COVID-19 pandemic, clinicians and researchers across the world are trying to understand the sequelae in patients recovered from COVID-19 infection. In this article, the […]

Post-COVID Interstitial Lung Disease—The Tip of the Iceberg

Namrata Kewalramani, MD,a,b,∗ Kerri-Marie Heenan, MB Bch, BAO,c Denise McKeegan, MB Bch, BAO, MSc,c and Nazia Chaudhuri, MD, PhDd Immunol Allergy Clin North Am. 2023 May; 43(2): 389–410. Published online 2023 Mar3. doi: 10.1016/j.iac.2023.01.004 PMCID: PMC9982726PMID: 37055095 The proportion of symptomatic patients with post-coronavirus 2019 (COVID-19) condition (long COVID) represents a significant burden on the individual as well as on the health care systems. […]

Post-COVID Interstitial Lung Disease: What you Need to Know

Apr 28, 2023 Pulmonary Fibrosis Foundation After being hospitalized for three months with COVID-19 and double pneumonia in 2020, Houston police officer Hito Bazan awoke one morning to discover that he couldn’t talk, eat, walk, or most importantly, breathe. Bazan was diagnosed with interstitial lung disease (ILD) known as pulmonary fibrosis (PF). Three years into […]

Lung Damage & Shortness of Breath After the COVID-19 Vaccine

September 18, 2023 The COVID Long-haul Foundation: Opinion Shortness of breath is a side effect of the COVID-19 vaccine that has been found in vaccinated individuals. It can be caused by a few different things, including: Myocarditis and Pericarditis After the COVID-19 Vaccine Myocarditis and pericarditis are two types of heart inflammation that can occur […]

Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID)

Jim M Wild1, Joanna C Porter2,3,4, Philip L Molyneaux5,6, Peter M George5,6, Stewart5, Richard James Allen7, Raminder Aul8, Kenneth Baillie9, Shaney L Barratt10, Paul Beirne11, Stephen M Bianchi12, John F Blaikley13,14, Jonathan Brooke15,16,17, Chaudhuri14,18, Guilhem Collier1, K Denneny2,3,4, Annemarie Docherty19, Fabbri5, Michael A Gibbons20,21, Fergus V Gleeson22, Bibek Gooptu23,24, Ian P Hall16,17, Neil A Hanley14,25, Melissa Heightman3, Toby E Hillman3, R Johnson16,17, Mark G Jones26,27, Khan16,17, Rod Lawson12, Puja Mehta2,28, Jane A Mitchell5, Platé2,29, Krisnah Poinasamy30, Jennifer K Quint5, Pilar […]